iPPI-DB

Inhibitors of Protein-Protein Interaction Database

Compound 1411

Identifiers

  • Canonical SMILES: 
    CN[C@@H](C)C(=O)N[C@@H](COC)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(C)=O)c1c[nH]c2ccc(F)cc12
  • IUPAC name: 
    (2S)-N-[(2S)-1-[(3aR,6S,6aR)-4-acetyl-6-(5-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-3-methoxy-1-oxopropan-2-yl]-2-(methylamino)propanamide
  • InChi: 
    InChI=1S/C24H32FN5O4/c1-13(26-3)23(32)28-20(12-34-4)24(33)29-8-7-21-22(29)18(11-30(21)14(2)31)17-10-27-19-6-5-15(25)9-16(17)19/h5-6,9-10,13,18,20-22,26-27H,7-8,11-12H2,1-4H3,(H,28,32)/t13-,18+,20-,21+,22+/m0/s1
  • InChiKey: 
    OZIABJPOLKJDSR-ACEXNVDFSA-N

External links


45138703

External search

Bibliography (1)

Publication Name
Stephen M. Condon, Matthew G. Laporte, Tetralogic Pharmaceuticals Corp.. . Iap inhibitors None. 72

Pharmacological data

Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 0 0 0

Targets

PPI family Best activity Diseases MMoA
XIAP / Smac 7.00 cancer Inhibition
Physicochemical filters
Descriptor Lipinski's RO5 Veber Pfizer's 3/75
Compliance
MW 473.24 g/mol
HBA 9
HBD 3
HBA + HBD 12
AlogP -0.45
TPSA 106.77
RB 7
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 1 0 0 0
Pharmacological data
Bibliography Name Target Competition Assay type Assay name Cell line Activity type Activity
WO2010033531 72 XIAP
P98170
Biochemical assay Fluorescence Polarization pKd (dissociation constant, -log10) 7.00
Ta Structure Name Drugbank ID
0.7881 Murepavadin DB14777
0.7632 Somatoprim DB12777
0.7534 Gramicidin D DB00027
0.7076 Tifuvirtide DB05413
0.6962 BQ-123 DB12054
0.6914 Anamorelin DB06645
0.6842 LTX-315 DB12748
0.6771 Daptomycin DB00080
0.6763 Nerofe DB14786
0.6725 Abarelix DB00106
0.6627 Acyline DB11906
0.6603 Oglufanide DB05779
0.6595 Somatostatin DB09099
0.6591 Barusiban DB12292
0.6573 Edratide DB15272